Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 3:8:20552076221097783.
doi: 10.1177/20552076221097783. eCollection 2022 Jan-Dec.

Assessing the performances of a chatbot to collect real-life data of patients suffering from primary headache disorders

Affiliations

Assessing the performances of a chatbot to collect real-life data of patients suffering from primary headache disorders

Benjamin Chaix et al. Digit Health. .

Abstract

Background: There are many scales for screening the impact of a disease. These scales are generally used to diagnose or assess the type and severity of a disease and are carried out by doctors. The chatbot helps patients suffering from primary headache disorders through personalized text messages. It could be used to collect patient-reported outcomes.

Objective: The aims of this study were (1) to study whether the collection and analysis of remote scores, without prior medical intervention, are possible by a chatbot, (2) to perform suggested diagnosis and define the type of headaches, and (3) to assess the patient satisfaction and engagement with the chatbot.

Method: Voluntary users of the chatbot were recruited online. They had to be over 18 and have a personal history of headaches. A questionnaire was presented (1) by text messages to the participants to evaluate migraines (2) based on the criteria of the International Headache Society. Then, the Likert scale (3) was used to assess overall satisfaction with the use of the chatbot.

Results: We included 610 participants with primary headache disorders. A total of 89.94% (572/610) participants had fully completed the questionnaire (eight items), 4.72% (30/610) had partially completed it, and 5.41% (33) had refused to complete it. Statistical analysis was performed on 86.01% (547/610) of participants. Auto diagnostic showed that 14.26% (78/547) participants had a tension headache, and 85.74% (469/547) had a probable migraine. In this population, 15.78% (74/469) suffered from migraine without probable aura, and 84.22% (395/469) had migraine without aura. The patient's age had a significant incidence regarding the auto diagnosis (P = .008<.05). The evaluation of overall satisfaction shows that a total of 93.9% (599/610) of users were satisfied or very satisfied regarding the timeliness of responses the chatbot provides.

Conclusion: The study confirmed that it was possible to obtain such a collection remotely, and quickly (average time of 3.24 min) with a high success rate (89.67% (547/610) participants who had fully completed the IHS questionnaire). Users were strongly engaged through chatbot: out of the total number of participants, we observed a very low number of uncompleted questionnaires (6.23% (38/610)). Conversational agents can be used to remotely collect data on the nature of the symptoms of patients suffering from primary headache disorders. These results are promising regarding patient engagement and trust in the chatbot.

Keywords: Chatbot; conversational agent; patient-reported outcomes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
The chatbot's interface.
Figure 2.
Figure 2.
Overall satisfaction rating.

Similar articles

Cited by

References

    1. Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol 2012; 19: 703–711. - PubMed
    1. Recommendations for clinical practice. Review of diagnosis and treatment of migraine in the adult and child October 2002. Professional recommendations and references: economic evaluation service. Rev. Neurol. (Paris) 2003; 159: S5–15. - PubMed
    1. Michel P, Pariente P, Duru G, et al. MIG ACCESS: a population-based, nationwide, comparative survey of access to care in migraine in France. Cephalalgia 1996; 16: 50–55. discussion 4. - PubMed
    1. Lanteri-Minet M, Valade D, Géraud G, et al. Prise en charge diagnostique et thérapeutique de la migraine chez l’adulte et chez l’enfant. Douleurs :Evaluation - Diagnostic - Traitement 2013; 14: 165–180. - PubMed
    1. GDB 2016 Disease and Injury and Prevalence Collaborators. Global, regional, and national incidence, prevalence and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the treatment global burden of disease study 2016. Lancet 2017; 390: 1211–1259. - PMC - PubMed

LinkOut - more resources